Targeted and untargeted profiling of biological fluids to screen for anabolic practices in cattle (Q57653801)

1

0 references

S. Weigel

2

0 references

J.-P. Antignac

3

0 references

M.H. Mooney

4

0 references

C. Elliott

5

0 references

M.W.F. Nielen

6

0 references

B. Le Bizec

Trends in Analytical Chemistry

7

0 references

publication date

December 2010

0 references

published in

0 references

volume

29

0 references

issue

11

0 references

page(s)

1269-1280

0 references

cites work

Recent developments in the use and abuse of growth promoters

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Options for veterinary drug analysis using mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Affinity-based biosensors as promising tools for gene doping detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Chemometric evaluation of urinary steroid profiles in doping control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Evidence for the presence of endogenous 19-norandrosterone in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Endogenous nandrolone metabolites in human urine: preliminary results to discriminate between endogenous and exogenous origin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Elimination kinetic of 17beta-estradiol 3-benzoate and 17beta-nandrolone laureate ester metabolites in calves' urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Estranediols profiling in calves' urine after 17beta-nandrolone laureate ester administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Growth hormones and sex steroid interactions at puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Combining biomarker screening and mass-spectrometric analysis to detect hormone abuse in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Methodology for profiling the steroid metabolome in animal tissues using ultraperformance liquid chromatography-electrospray-time-of-flight mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Metabolomics approach to anabolic steroid urine profiling of bovines treated with prohormones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Regulation of tissue beta-adrenergic, glucocorticoid and androgen receptors induced by repeated exposure to growth promoters in male veal calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Use of hepatic protein biomarkers for tracing the exposure of veal calves to illegal growth-promoters: investigations on experimental samples and preliminary application under field conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Cytochrome P450 inhibition profile in liver of veal calves administered a combination of 17beta-estradiol, clenbuterol, and dexamethasone for growth-promoting purposes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Effects of dexamethasone, administered for growth promoting purposes, upon the hepatic cytochrome P450 3A expression in the veal calf

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Effects of an illicit cocktail on serum immunoglobulins, lymphocyte proliferation and cytokine gene expression in the veal calf.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Administration of dexamethasone per os in finishing bulls. II. Effects on blood parameters used as indicators of animal welfare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Serum antioxidant enzyme activities and oxidative stress parameters as possible biomarkers of exposure in veal calves illegally treated with dexamethasone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Integrated analytical approach in veal calves administered the anabolic androgenic steroids boldenone and boldione: urine and plasma kinetic profile and changes in plasma protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Effect of growth-promoting 17beta-estradiol, 19-nortestosterone and dexamethasone on circulating levels of nine potential biomarker candidates in veal calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Plasma biomarker profiling in the detection of growth promoter use in calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Biosensor-based detection of reduced sex hormone-binding globulin binding capacities in response to growth-promoter administrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

A Specific Radioimmunoassay for the Growth Hormone (GH)-Dependent Somatomedin-Binding Protein: Its Use for Diagnosis of GH Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

On the alterations in serum concentration of somatotropin and insuline-like growth factor 1 in lactating cows after the treatment with a little studied recombinant bovine somatotropin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Short-term oral oestrogen therapy dissociates the growth hormone/insulin-like growth factor-I axis without altering energy metabolism in premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Stimulation of circulating insulin-like growth factor I (IGF-I) and insulin-like growth factor binding proteins (IGFBP) due to administration of a combined trenbolone acetate and estradiol implant in feedlot cattle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Differential exoprotease activities confer tumor-specific serum peptidome patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Quantitative proteomics: a review of different methodologies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Perspective: proteomic approach to detect biomarkers of human growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

The use of omic technologies for biomarker development to trace functions of anabolic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Modification of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

17beta-oestradiol-induced gene expression in cattle prostate: biomarkers to detect illegal use of growth promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Moving cancer diagnostics from bench to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Gene expression in hair follicle dermal papilla cells after treatment with stanozolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Identification of potential gene expression biomarkers for the surveillance of anabolic agents in bovine blood cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Feasibility of a clinical chemical analysis approach to predict misuse of growth promoting hormones in cattle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Analyzing the physiological signature of anabolic steroids in cattle urine using pyrolysis/metastable atom bombardment mass spectrometry and pattern recognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Effects of a beta-agonist (clenbuterol) on growth, carcass composition, protein and energy metabolism of veal calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Effects of the beta-adrenergic agonist clenbuterol in cows: lipid metabolism, milk production, pharmacokinetics, and residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Effect of castration and steroid sex hormones on rat kidney transamidinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Detection of secondary biomarker of met-eGH as a strategy to screen for somatotropin misuse in horseracing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Validation and application of a yeast bioassay for screening androgenic activity in calf urine and feed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Bioassay-Directed Identification of Estrogen Residues in Urine by Liquid Chromatography Electrospray Quadrupole Time-of-Flight Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010

Development, validation and implementation of a receptor based bioassay capable of detecting a broad range of beta-agonist drugs in animal feedingstuffs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRAC.2010.06.010